Minerva Neurosciences (NERV) Net Shares Issued and Repurchased (2013 - 2026)
Powered by 
Analysis
Minerva Neurosciences (NERV) Net Shares Issued and Repurchased (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Minerva Neurosciences | 207.37 Mn | 207.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 812,169.00 |
| Dec 31, 2025 | 6.77 Mn |
| Mar 31, 2025 | 20,218.00 |
| Dec 31, 2024 | 451,500.00 |
| Mar 31, 2024 | 41,872.00 |
| Dec 31, 2023 | 483,800.00 |
| Mar 31, 2023 | 20,218.00 |
| Dec 31, 2022 | 436,000.00 |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Dec 31, 2019 | 671,656.00 |
| Dec 31, 2018 | 215,000.00 |
| Mar 31, 2018 | 40,000.00 |
| Dec 31, 2017 | 775,000.00 |
| Mar 31, 2017 | 145,000.00 |
| Dec 31, 2016 | 60,000.00 |
| Dec 31, 2015 | 1.88 Mn |
| Mar 31, 2015 | 25,000.00 |
| Dec 31, 2014 | 1.98 Mn |